(Q35309576)

7 August 2017

1 reference

title

Detection of autoantibodies in a point-of-care rheumatology setting (English)

1 reference

7 August 2017

1 reference

Konstantin N Konstantinov

series ordinal

1

1 reference

7 August 2017

Antonios Tzamaloukas

series ordinal

2

1 reference

7 August 2017

Robert L Rubin

series ordinal

3

1 reference

7 August 2017

publication date

18 May 2013

1 reference

7 August 2017

published in

Autoimmunity highlights

1 reference

7 August 2017

volume

4

1 reference

7 August 2017

issue

2

1 reference

7 August 2017

page(s)

55-61

1 reference

https://scigraph.springernature.com/pub.10.1007/s13317-013-0052-9

7 August 2017

exact match

0 references

cites work

Biomarkers in rheumatology, now and in the future

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389050

Validation of new biomarkers in systemic autoimmune diseases

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389050

Biosensors in clinical chemistry - 2011 update

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389050

Association of endogenous anti-interferon-α autoantibodies with decreased interferon-pathway and disease activity in patients with systemic lupus erythematosus

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389050

Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389050

Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389050

Immediate determination of ACPA and rheumatoid factor--a novel point of care test for detection of anti-MCV antibodies and rheumatoid factor using a lateral-flow immunoassay

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389050

Quantitative, reagentless, single-step electrochemical detection of anti-DNA antibodies directly in blood serum

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389050

Serum levels of autoantibodies against C-reactive protein correlate with renal disease activity and response to therapy in lupus nephritis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389050

Rapid serological detection of autoantibodies associated with Sjögren's syndrome

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389050

Anti-C1q antibodies antedate patent active glomerulonephritis in patients with systemic lupus erythematosus

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389050

Diagnostic value of anti-topoisomerase I antibodies in a large monocentric cohort

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389050

Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389050

ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389050

Novel biosensor-based analytic device for the detection of anti-double-stranded DNA antibodies

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389050

Association of antinucleosome antibodies with disease flare in serologically active clinically quiescent patients with systemic lupus erythematosus

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389050

Point-of-care immunotesting: approaching the analytical performance of central laboratory methods

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389050

ANCA and anti-GBM antibodies in diagnosis and follow-up of vasculitic disease.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389050

Anti-neutrophil cytoplasmic antibody (ANCA) levels directed against proteinase-3 and myeloperoxidase are helpful in predicting disease relapse in ANCA-associated small-vessel vasculitis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389050

Rheumatologic diseases in the intensive care unit: epidemiology, clinical approach, management, and outcome

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389050

Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-DNA antibody tests

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389050

International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389050

Epidemiology and estimated population burden of selected autoimmune diseases in the United States

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389050

Relationship of beliefs and behavior in test ordering

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389050

Fluctuations of anticardiolipin antibody levels in patients with systemic lupus erythematosus: a prospective study

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389050

Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389050

Medical care expenditures and earnings losses of persons with arthritis and other rheumatic conditions in the United States in 1997: total and incremental estimates

12 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13317-013-0052-9

Evaluative laboratory testing practices of United States rheumatologists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13317-013-0052-9

Diversity of PR3-ANCA epitope specificity in Wegener's granulomatosis. Analysis using the biosensor technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13317-013-0052-9

Relationship between anti-double-stranded DNA antibodies and exacerbation of renal disease in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13317-013-0052-9

Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13317-013-0052-9

Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13317-013-0052-9

Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13317-013-0052-9

Association of IgG anti-NR2 glutamate receptor antibodies in cerebrospinal fluid with neuropsychiatric systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13317-013-0052-9

Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13317-013-0052-9

Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13317-013-0052-9

Antimyeloperoxidase antibodies are a useful marker of disease activity in antineutrophil cytoplasmic antibody-associated vasculitides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13317-013-0052-9

Serial ANCA titers: useful tool for prevention of relapses in ANCA-associated vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13317-013-0052-9

Anti-glomerular basement membrane autoantibodies against different target antigens are associated with disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13317-013-0052-9

Development of antidrug antibodies against adalimumab and association with disease activity and treatment failure during long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13317-013-0052-9

Antibodies to amino acid 200-239 (p200) of Ro52 as serological markers for the risk of developing congenital heart block.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13317-013-0052-9

Anti-DFS70 antibodies in 597 healthy hospital workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13317-013-0052-9

Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13317-013-0052-9

The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13317-013-0052-9

Biosensor analysis of beta2-glycoprotein I-reactive autoantibodies: evidence for isotype-specific binding and differentiation of pathogenic from infection-induced antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13317-013-0052-9

Short-Term Kinetics of the Humoral Anti-Clq Response in SLE Using the ELISPOT Method: Fast Decline in Production in Response to Steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13317-013-0052-9

Accuracy of Anticardiolipin Antibodies in Identifying a History of Thrombosis Among Patients With Systemic Lupus Erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13317-013-0052-9

Rapid detection of anti-chromatin autoantibodies in human serum using a portable electrochemical biosensor

21 January 2018

1 reference

12 December 2020

Longitudinal analysis of autoantibody response to topoisomerase I in systemic sclerosis

1 reference

12 December 2020

Correlation of serum anti‐DNA topoisomerase I antibody levels with disease severity and activity in systemic sclerosis

1 reference

12 December 2020

Anti-C1q antibodies: association with nephritis and disease activity in systemic lupus erythematosus

1 reference

12 December 2020

Autoantibodies in ANCA-associated Vasculitis

1 reference

12 December 2020

Acquired thrombotic thrombocytopenic purpura: ADAMTS13 activity, anti-ADAMTS13 autoantibodies and risk of recurrent disease

1 reference

12 December 2020

Anti-nuscleosome antibody, a reliable indicator for lupus nephritis

1 reference

12 December 2020

Anti-nucleosome antibodies as a disease activity marker in patients with systemic lupus erythematosus

1 reference

12 December 2020

Biomolecular interaction monitoring of autoantibodies by scanning surface plasmon resonance microarray imaging

1 reference

12 December 2020

The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants

1 reference

12 December 2020

Autoantibody response to the Ro/La particle may predict outcome in neonatal lupus erythematosus

1 reference

12 December 2020

Do we need autoimmune disease units in hospitals?

1 reference

12 December 2020

Quartz crystal microbalance immunosensor for the detection of antibodies to double-stranded DNA

1 reference

12 December 2020

Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome

1 reference

12 December 2020

Arthritis patient as an emergency case at a university hospital

1 reference

12 December 2020

How to assess musculoskeletal conditions. Assessment of disease activity

1 reference

12 December 2020

Diagnostic utility of an anti-CCP point-of-care immunotest in Chinese patients with rheumatoid arthritis

1 reference

12 December 2020

10.1007/S13317-013-0052-9

Identifiers

DOI

1 reference

release_cymrl3nzsjfexddngfyit7qlhi

7 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cymrl3nzsjfexddngfyit7qlhi

24 November 2022

mapped directly with Wikidata item

PMC publication ID

4389050

1 reference

7 August 2017

1 reference